SMTL ID : 7xqe.2 (1 other biounit)

Crystal Structure of human RORgamma (C455E) LBD in complex with compound XY039

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.57 Å

Oligo State

homo-dimer

Ligands

2 x H4I: 2,4-difluoro-N-(1-((4-(trifluoromethyl)benzyl)sulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)benzenesulfonamide(Non-covalent)

H4I.1: 17 residues within 4Å: Chain A: L.47, C.80, H.83, L.84, A.87, M.118, V.121, L.122, R.124, M.125, A.128, V.136, F.137, F.138, F.148, I.157, I.160 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.84, A:A.87, A:V.121, A:V.136, A:F.138, A:F.148, A:I.157, A:I.160 Hydrogen bonds: A:F.137 H4I.3: 17 residues within 4Å: Chain B: L.47, C.80, H.83, L.84, A.87, M.118, V.121, L.122, R.124, M.125, A.128, V.136, F.137, F.138, F.148, I.157, I.160 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:L.84, B:A.87, B:V.121, B:V.136, B:F.138, B:F.148, B:I.157, B:I.160 Hydrogen bonds: B:F.137

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 4 residues within 4Å: Chain A: W.77, L.156, I.160 Chain B: W.77 No protein-ligand interaction detected (PLIP) GOL.4: 4 residues within 4Å: Chain A: W.77 Chain B: W.77, L.156, I.160 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wu, X.S. et al., Discovery and pharmacological characterization of 1,2,3,4-tetrahydroquinoline derivatives as ROR gamma inverse agonists against prostate cancer. Acta Pharmacol.Sin. (2024)

Release Date

2023-05-31

Peptides

Nuclear receptor ROR-gamma: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
B

Nuclear receptor ROR-gamma

Related Entries With Identical Sequence